Human immunoglobulin (pH4, Shanxi Kangbao Biological)

人免疫球蛋白(ph4,山西康宝)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman immunoglobulin (pH4, Shanxi Kangbao Biological)
Drug Alias NameN/A
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsUrticariaDermatitis, Allergic ContactAsthma
Global Approved IndicationsUrticariaDermatitis, Allergic ContactAsthma
Approved Indications in ChinaUrticariaDermatitis, Allergic ContactAsthma
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsUrticariaDermatitis, Allergic ContactAsthma
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA02
Related LinksDrugBankKEGG